Antibiotic use in children with multisystem inflammatory syndrome associated with SARS-CoV-2

Acta Paediatr. 2022 Aug;111(8):1583-1584. doi: 10.1111/apa.16416. Epub 2022 Jun 5.

Authors

Tracy N Zembles¹, Katie M Ray¹, Evelyn M Kuhn², Anna R Huppler³

Affiliations

¹ Department of Enterprise Safety, Children's Wisconsin, Milwaukee, Wisconsin, USA.
² Department of Business Intelligence and Data Warehousing, Children's Wisconsin, Milwaukee, Wisconsin, USA.
³ Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

No abstract available

Publication types

Letter

MeSH terms

Anti-Bacterial Agents / therapeutic use
COVID-19 Drug Treatment*
COVID-19* / complications
Child
Humans
SARS-CoV-2*
Systemic Inflammatory Response Syndrome / drug therapy

Substances

Anti-Bacterial Agents

Supplementary concepts

pediatric multisystem inflammatory disease, COVID-19 related